Economic Impact of Allergic Diseases and Asthma—The <scp>HEAD</scp> Pan‐European Registry

The Health Economics of Allergic Diseases (HEAD) registry is a European-based registry developed by the European Academy of Allergy and Clinical Immunology in collaboration with national allergy societies to facilitate standardised allergic disease management. Using an observational design, this first registry-based study describes care patterns for allergic diseases and their impact on the healthcare system (diagnostic and management costs), society (missed work/school days and disability pension/support) and patients (out-of-pocket costs) in 778 adults and children with allergic rhinitis, asthma, atopic dermatitis and food allergy, from four countries (Belgium, Italy, Romania and Spain). The average total costs per patient and per year were €1329.55 ± 1947.39, with indirect costs of €338.68 ± 1629.61. Direct costs consisted of €82.74 ± 585.90 for hospitalisations, €17.50 ± 125.07 for the emergency department, €172.94 ± 323.17 for specialists, €22.70 ± 132.42 for primary care, €4.85 ± 136.84 for psychologists, €21.24 ± 82.47 for diagnosis and €104.81 ± 469.26 for treatments. Indirect costs were out-of-pocket consultation fees (€16.24 ± 106.40), medications (€161.90 ± 710.58), transportation (€44.15 ± 218.51), private insurance (€16.77 ± 157.91), avoidance (€8.65 ± 92.99) and environmental control (€99.33 ± 955.23). Adults missed 1.02 ± 3.20 workdays, children missed 0.53 ± 2.18 schooldays and burdened their families with 1.38 ± 13.83 lost days. There was a high degree of heterogeneity across countries for management patterns and for costs. The significant burden of allergic diseases calls for immediate action for better management.

Authors

Institutions

Publication Details

Journal
Allergy
Published
2025-05-20
DOI
https://doi.org/10.1111/all.16596
Citations
6
Primary Topic
Asthma and respiratory diseases
Type
article
Field-Weighted Citation Impact
6.99

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Economic Impact of Allergic Diseases and Asthma—The HEAD Pan‐European Registry

Loreto Carmona, Maria Beatrice Bilò, K El, Paulo Nogueira et al.
6 citations
Allergy
Asthma and respiratory diseases
6.99
article

Economic Impact of Allergic Diseases and Asthma—The HEAD Pan‐European Registry

Loreto Carmona, Maria Beatrice Bilò, K El, Paulo Nogueira, Vicente Javier Albendiz, Andrea Sangalli, Selda Ali, Ioana Agache, Roxana Silvia Bumbăcea, Darío Antolín‐Amérigo, E. Bradatan, Federica Rivolta, Ibon Eguíluz‐Gracia, Marı́a José Torres, Maria Miguel Oliveira, Águeda Concepción Lario Cuenda
article en
6 citations

Abstract

The Health Economics of Allergic Diseases (HEAD) registry is a European-based registry developed by the European Academy of Allergy and Clinical Immunology in collaboration with national allergy societies to facilitate standardised allergic disease management. Using an observational design, this first registry-based study describes care patterns for allergic diseases and their impact on the healthcare system (diagnostic and management costs), society (missed work/school days and disability pension/support) and patients (out-of-pocket costs) in 778 adults and children with allergic rhinitis, asthma, atopic dermatitis and food allergy, from four countries (Belgium, Italy, Romania and Spain). The average total costs per patient and per year were €1329.55 ± 1947.39, with indirect costs of €338.68 ± 1629.61. Direct costs consisted of €82.74 ± 585.90 for hospitalisations, €17.50 ± 125.07 for the emergency department, €172.94 ± 323.17 for specialists, €22.70 ± 132.42 for primary care, €4.85 ± 136.84 for psychologists, €21.24 ± 82.47 for diagnosis and €104.81 ± 469.26 for treatments. Indirect costs were out-of-pocket consultation fees (€16.24 ± 106.40), medications (€161.90 ± 710.58), transportation (€44.15 ± 218.51), private insurance (€16.77 ± 157.91), avoidance (€8.65 ± 92.99) and environmental control (€99.33 ± 955.23). Adults missed 1.02 ± 3.20 workdays, children missed 0.53 ± 2.18 schooldays and burdened their families with 1.38 ± 13.83 lost days. There was a high degree of heterogeneity across countries for management patterns and for costs. The significant burden of allergic diseases calls for immediate action for better management.

AllergyVol. 80(6)
Marche Polytechnic University (IT), University of Lisbon (PT), Carol Davila University of Medicine and Pharmacy (RO), Instituto Cajal (ES), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), Transylvania University of Brașov (RO), Centre Hospitalier Chrétien (BE), Centre Hospitalier Régional de Namur (BE), Hospital Regional Universitario de Málaga (ES), Instituto de Arqueología-Mérida (ES), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Instituto de Salud Musculoesquelética (ES), Istituto Nazionale di Riposo e Cura per Anziani (IT), Instituto de Investigación Biomédica de Málaga (ES)
European Academy of Allergy and Clinical Immunology
Openalex Percentile: Top 3%
Asthma and respiratory diseases
6.99
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.